Omega Therapeutics slips after popping 30% in Nasdaq debut
30/07/2021 18:07
** Shares of biotech co Omega Therapeutics Inc OMGA.O down
~3% at $16.4 after Nasdaq debut
** OMGA opened at $22.10, 30% above IPO price of $17 per
share urn:newsml:reuters.com:*:nPn9HG1xha
** Co sold 7.4 mln shares in IPO on Thursday, raising about
$125.8 mln
** Omega is a development-stage biopharmaceutical company
** Goldman Sachs, Jefferies and Piper Sandler were the joint
book-running managers of the offering
(Reporting by Sohini Podder in Bengaluru)
((sohini.podder@thomsonreuters.com))
Recent news on Omega Liquidating
See all newsBrief: Omega Therapeutics Files For Chapter 11 Bankruptcy In U.S. - Court Filing
Brief: Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets
Brief: Omega Therapeutics Receives Notice Of Default Under The Loan And Security Agreement Between Company And Banc Of California
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence